Top stocks and shares to buy in August

Andy Ross looks at some of the best shares to buy for his portfolio while much of the City is on the beach.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Like many private investors, I like to cast my net wide to find the best stocks and shares to buy. Depending on what the market does in August, it’s possible I’ll buy shares from the FTSE 100 all the way down to newly listed companies and small caps.

With that in mind then, these are some of the shares I might buy for my portfolio.

One of my top shares to buy in August

I’ve previously been bullish on a number of FTSE 100 shares. Croda (LSE: CRDA) is one I’m confident about. Just this week, the chemicals company said it expected annual profit to be well ahead of expectations. This kind of confidence is often good for the share price and indeed the shares were up on the day of the announcement, even as the market fell.

The results also showed that pretax profit rose 41% to £204.1m in the six months to the end of June from a year earlier as sales surged 39% to £934m. 

I think the end markets that Croda serves mean it should continue to do well in future. That in turn should help Croda keep growing. Its customers are typically in life sciences and personal care – both of which I think are growth industries. They do serve a wider customer base, but these are the most exciting ones.

The biggest potential downside I’m keeping an eye out for is the valuation. The quality of Croda hasn’t gone unnoticed by investors. It means the shares trade on a price-to-earnings ratio of 47.

However, the quality means I think it may be one of the best stocks I can buy in August – especially if the shares dip. I’ll add it to my portfolio if there’s strong summer selling. I’d be tempted back in at around the 7,500p mark. 

The small-cap option

I’ll end with one of the smaller companies I like the look of. Recent results sent SourceBio International (LSE: SIO) shares flying. That partially redeemed a share price that has been falling through much of the year to date.

The results showed that in the first half, revenue rose nearly fourfold to £37.3m.

The company said the return of elective surgery led to a recovery in its cellular pathology business. This is a return to normal that I think is likely to continue 

Much of the legacy business is returning to normal, while the new infectious disease testing business is expected to benefit from increasing travel in the second half.

Despite this, the shares are very cheap on a forward P/E of only around four.

The main risk in my view is around the limited outlook for infectious diseases. How long will we need testing after everyone is vaccinated? Then what will SourceBio do with all that capacity it has invested in and what will that mean for its efficiency?

Overall, although the future is uncertain, the shares are so cheap, SourceBio is one I’ll think about adding to my own portfolio in August.

Just to end, I am also thinking about National World, a business that recently listed and that I covered here for The Motley Fool.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Andy Ross owns no share mentioned. The Motley Fool UK has recommended Croda International. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »